Patent US4579821A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4579821A Expired / Lapsed US ⏱️ 0.0 years remaining

Control of DNA sequence transcription

Assignee: University Patents Inc
•
Filing: 1981-11-23
•
Granted: 1986-04-01
•
Expires: 2001-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The transcription of DNA sequences in living cells is subjected to external regulation by incorporation of promoter/regulator DNA sequences responsive to metals and/or steroids. More particularly, regulation of the transcription of selected exogenous DNA sequences incorporated into eukaryotic host cells is facilitated by operative association (e.g., fusion) of the selected sequence to a promoter/regulator DNA sequence which is positively or negatively responsive to environmental variation in the concentration of heavy metal ions and/or steroid hormones. As an example, a structural gene for thymidine kinase from herpes simplex virus, fused to the promoter/regulator DNA sequence of a mouse metallothionein-I gene and incorporated on a suitable DNA plasmid vector, is introduced into mouse embryos and stably incorporated therein. Gene expression in differentiated cells of adult mice resulting from the embryos is subsequently regulatable by administration of heavy metals such as cadmium or steroid hormones such as the glucocorticoid, dexamethasone.

Inventors

  • 👤 Richard D. Palmiter
  • 👤 Ralph L. Brinster

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 16:05
CPC Classifications
C; C12; C12N; C12N15/00

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 57 words
A process for subjecting the transcription of a selected DNA sequence to external control under given environmental conditions which comprises the steps of: providing a selected isolated structural gene that is transcriptionally responsive to a mouse metallothionein-I promotor/regulator DNA sequence under the given environmental conditions; and operatively fusing the selected structural gene with said promoter/regulator DNA sequence.
Claim 2
Dependent Claim 57 words
A process for subjecting the transcription of a selected DNA sequence to external control under given environmental conditions which comprises the steps of: providing a selected isolated structural gene that is transcriptionally responsive to a mouse metallothionein-I promotor/regulator DNA sequence under the given environmental conditions; and operatively fusing the selected structural gene with said promoter/regulator DNA sequence.
Claim 3
Dependent Claim 76 words
In the genetic engineering process for securing transcription and expression of a selected isolated structural gene sequence in a mammalian host cell wherein said selected structural gene is stably incorporated as a chromosomal or extrachromosomal constituent of the host, the improvement comprising the step of: operatively fusing with said selected structural gene sequence a mouse metallothionein-I promoter/regulator DNA sequence which is responsive to environmental variations within the host cell in the concentration of ions of metal.
Claim 4
Dependent Claim 76 words
In the genetic engineering process for securing transcription and expression of a selected isolated structural gene sequence in a mammalian host cell wherein said selected structural gene is stably incorporated as a chromosomal or extrachromosomal constituent of the host, the improvement comprising the step of: operatively fusing with said selected structural gene sequence a mouse metallothionein-I promoter/regulator DNA sequence which is responsive to environmental variations within the host cell in the concentration of ions of metal.
Claim 5
Dependent Claim 41 words
A fusion gene product, suitable for use in genetic transformation of a mammalian host cell, said product comprising: a non mouse metallothionein structural gene sequence to be incorporated in said host cell operatively fused with a mouse metallothionein-I promoter/regulator DNA sequence.
Claim 6
Dependent Claim 41 words
A fusion gene product, suitable for use in genetic transformation of a mammalian host cell, said product comprising: a non mouse metallothionein structural gene sequence to be incorporated in said host cell operatively fused with a mouse metallothionein-I promoter/regulator DNA sequence.
Claim 7
Dependent Claim 18 words
A genetic transformation vector comprising a DNA plasmid or virus including a fusion gene according to claim 3.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-03-31 1989-09-30 1990-04-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-03-31 1993-09-30 1994-04-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-03-31 1997-09-30 1998-04-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag